Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Murphy

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2007
Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa?Charlotte Sakarovitch, Francois Rouet, Gary Murphy, et al.
AIDS and Behavior|May 21, 2013
High percentage of recent HIV infection leading to onward transmission in Odessa, Ukraine associated with young adultsRuth Simmons, Igor Semenenko, Maria Tolpina, et al.
The Journal of Infectious Diseases|September 26, 2025
Real-world prevalence of non-integrase INSTI resistance-associated mutations and virological outcomes in people who have recently acquired HIV-1 in the UKChristine Kelly, James S Lester, Daniel Bradshaw, et al.
Plos One|January 28, 2017
Chlamydia trachomatis Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994-2012)Sarah C Woodhall, Gillian S Wills, Patrick J Horner, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2020
Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UKJean L Mbisa, Juan Ledesma, Peter Kirwan, et al.
Plos One|May 25, 2019
The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpxKristi Huik, Pilleriin Soodla, Merit Pauskar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 3, 2017
A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key PopulationsEsther Fearnhill, Annabelle Gourlay, Ruslan Malyuta, et al.
BMC Infectious Diseases|October 28, 2019
Interpreting HIV diagnostic histories into infection time estimates: analytical framework and online toolEduard Grebe, Shelley N Facente, Jeremy Bingham, et al.
AIDS (London, England)|March 15, 2019
A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test resultsChristopher D Pilcher, Travis C Porco, Shelley N Facente, et al.
Plos One|July 27, 2019
Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillanceJoseph B Sempa, Alex Welte, Michael P Busch, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2007
Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa?Charlotte Sakarovitch, Francois Rouet, Gary Murphy, et al.
AIDS and Behavior|May 21, 2013
High percentage of recent HIV infection leading to onward transmission in Odessa, Ukraine associated with young adultsRuth Simmons, Igor Semenenko, Maria Tolpina, et al.
The Journal of Infectious Diseases|September 26, 2025
Real-world prevalence of non-integrase INSTI resistance-associated mutations and virological outcomes in people who have recently acquired HIV-1 in the UKChristine Kelly, James S Lester, Daniel Bradshaw, et al.
Plos One|January 28, 2017
Chlamydia trachomatis Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994-2012)Sarah C Woodhall, Gillian S Wills, Patrick J Horner, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2020
Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UKJean L Mbisa, Juan Ledesma, Peter Kirwan, et al.
Plos One|May 25, 2019
The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpxKristi Huik, Pilleriin Soodla, Merit Pauskar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 3, 2017
A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key PopulationsEsther Fearnhill, Annabelle Gourlay, Ruslan Malyuta, et al.
BMC Infectious Diseases|October 28, 2019
Interpreting HIV diagnostic histories into infection time estimates: analytical framework and online toolEduard Grebe, Shelley N Facente, Jeremy Bingham, et al.
AIDS (London, England)|March 15, 2019
A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test resultsChristopher D Pilcher, Travis C Porco, Shelley N Facente, et al.
Plos One|July 27, 2019
Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillanceJoseph B Sempa, Alex Welte, Michael P Busch, et al.
Pageof 5